Medicare Enrolled
Dr. Louay Hanna, M.D.
Medical Oncology · Hickory, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hanna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hanna?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hanna
Dr. Louay Hanna is a medical oncology specialist in Hickory, NC, with 15 years of NPI registration. Based on federal Medicare data, Dr. Hanna performed 39,296 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hanna received a total of $46,808 from 107 pharmaceutical and/or device companies across 1278 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hanna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 4% volume in NC
$46,808 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗39,296
Medicare services
Top 4% in NC for medical oncology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 9,800 | $43 | $92 |
| Denosumab injection (Prolia/Xgeva) | 8,760 | $18 | $39 |
| Iron infusion (Monoferric) | 7,400 | $17 | $36 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,616 | $6 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,047 | $8 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,689 | $0 | $3 |
| Anti-nausea injection (ondansetron/Zofran) | 908 | $0 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
841 | $92 | $167 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
557 | $134 | $243 |
| Anti-nausea injection (Aloxi/palonosetron) | 430 | $1 | $43 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
413 | $10 | $38 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
365 | $13 | $33 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
286 | $54 | $114 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
281 | $2 | $235 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
260 | $97 | $336 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
227 | $22 | $86 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
178 | $12 | $59 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
146 | $48 | $184 |
| Injection, potassium chloride, per 2 meq | 145 | $0 | $3 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
141 | $16 | $40 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
136 | $7 | $14 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
125 | $49 | $185 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
108 | $0 | $0 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
102 | $16 | $39 |
| Adrenocorticotropic hormone (ACTH) level test A blood test that measures the amount of adrenocorticotropic hormone in your body. |
99 | $37 | $91 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $21 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $66 | $115 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
86 | $0 | $14 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $120 | $271 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
77 | $1 | $9 |
| PSA test (prostate cancer screening) | 69 | $18 | $44 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
62 | $29 | $70 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
60 | $10 | $39 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 60 | $340 | $853 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 56 | $20 | $50 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
55 | $24 | $122 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
53 | $2 | $15 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
51 | $68 | $145 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
47 | $8 | $10 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
45 | $18 | $45 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
41 | $3 | $14 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
41 | $18 | $146 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $16 | $50 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 30 | $20 | $58 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $135 | $315 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
22 | $16 | $38 |
| New patient office visit, complex (60-74 min) | 22 | $169 | $345 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
17 | $27 | $111 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
14 | $47 | $132 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.1% high complexity
65.8% medium
13.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$46,808
Total received (2018-2024)
Avg $6,687/year across 7 years
Top 20% in NC for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
107
Companies
1,278
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,680
2023
$8,550
2022
$4,041
2021
$2,299
2020
$5,150
2019
$16,379
2018
$2,709
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$3,812
BeiGene USA, Inc.
$718
Novartis Pharmaceuticals Corporation
$299
PFIZER INC.
$284
Merck Sharp & Dohme LLC
$215
Janssen Biotech, Inc.
$215
Takeda Pharmaceuticals U.S.A., Inc.
$177
Bayer Healthcare Pharmaceuticals Inc.
$167
Eisai Inc.
$159
Genentech USA, Inc.
$99
Incyte Corporation
$95
ARRAY BIOPHARMA INC
$80
GlaxoSmithKline, LLC.
$73
Exelixis Inc.
$73
Lilly USA, LLC
$67
Daiichi Sankyo Inc.
$59
SpringWorks Therapeutics, Inc.
$54
Gilead Sciences, Inc.
$54
GENZYME CORPORATION
$53
ABBVIE INC.
$52
PUMA BIOTECHNOLOGY, INC.
$48
Karyopharm Therapeutics Inc.
$47
E.R. Squibb & Sons, L.L.C.
$45
Genmab U.S., Inc.
$45
ACCORD HEALTHCARE, INC.
$42
Aveo Pharmaceuticals, Inc.
$40
Adaptive Biotechnologies Corporation
$38
SERVIER PHARMACEUTICALS LLC
$35
Ipsen Biopharmaceuticals, Inc
$34
Avyxa Pharma, LLC
$34
ADC Therapeutics America, Inc.
$33
Pharmacosmos Therapeutics Inc.
$32
Azurity Pharmaceuticals, Inc.
$31
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Janssen Pharmaceuticals, Inc
$26
Novocure Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Coherus Biosciences Inc.
$23
PharmaEssentia USA Corporation
$22
Celgene Corporation
$22
TAIHO ONCOLOGY, INC.
$22
Myriad Genetic Laboratories, Inc.
$20
Alexion Pharmaceuticals, Inc.
$19
EMD Serono, Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
Kite Pharma, Inc.
$17
Kyowa Kirin, Inc.
$16
Stemline Therapeutics Inc.
$15
SHIELD THERAPEUTICS INC
$14
Mirati Therapeutics, Inc.
$14
SOBI, INC
$13
Spectrum Pharmaceuticals Inc.
$13
Top 3 companies account for 62.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$7,993
E.R. Squibb & Sons, L.L.C.
$6,224
Lilly USA, LLC
$5,097
Janssen Biotech, Inc.
$3,822
Novartis Pharmaceuticals Corporation
$2,460
Seattle Genetics, Inc.
$1,600
Genmab U.S., Inc.
$1,580
Genentech USA, Inc.
$1,513
PFIZER INC.
$1,424
Amgen Inc.
$1,132
Daiichi Sankyo Inc.
$1,010
Bayer HealthCare Pharmaceuticals Inc.
$981
BeiGene USA, Inc.
$833
Merck Sharp & Dohme Corporation
$765
Takeda Pharmaceuticals U.S.A., Inc.
$712
Pfizer Inc.
$625
Celgene Corporation
$620
Incyte Corporation
$587
GENZYME CORPORATION
$584
Exelixis Inc.
$554
Merck Sharp & Dohme LLC
$500
Eisai Inc.
$462
Seagen Inc.
$354
Karyopharm Therapeutics Inc.
$323
GlaxoSmithKline, LLC.
$237
Bayer Healthcare Pharmaceuticals Inc.
$215
ARRAY BIOPHARMA INC
$210
Gilead Sciences, Inc.
$191
Ipsen Biopharmaceuticals, Inc
$176
Athenex Pharmaceutical Division, LLC
$175
Pharmacyclics LLC, An AbbVie Company
$159
JAZZ PHARMACEUTICALS INC.
$158
EISAI INC.
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
Kite Pharma, Inc.
$127
ADC Therapeutics America, Inc.
$122
Myriad Genetic Laboratories, Inc.
$119
Teva Pharmaceuticals USA, Inc.
$110
ABBVIE INC.
$109
Taiho Oncology, Inc.
$103
Alexion Pharmaceuticals, Inc.
$97
Astellas Pharma US Inc
$96
Coherus Biosciences Inc.
$84
PUMA BIOTECHNOLOGY, INC.
$83
EMD Serono, Inc.
$79
SERVIER PHARMACEUTICALS LLC
$73
Novocure Inc.
$72
Epizyme, Inc.,
$72
AVEO Pharmaceuticals, Inc.
$70
Foundation Medicine, Inc.
$67
Pharmacyclics LLC, an AbbVie Company
$67
Aveo Pharmaceuticals, Inc.
$64
Stemline Therapeutics Inc.
$59
Deciphera Pharmaceuticals Inc.
$58
PharmaEssentia USA Corporation
$57
Regeneron Healthcare Solutions, Inc.
$56
SpringWorks Therapeutics, Inc.
$54
Kyowa Kirin, Inc.
$54
Adaptive Biotechnologies Corporation
$52
Janssen Pharmaceuticals, Inc
$52
Mirati Therapeutics, Inc.
$48
Acceleron Pharma, Inc.
$42
ACCORD HEALTHCARE, INC.
$42
TOLMAR Pharmaceuticals, Inc.
$42
Mylan Pharmaceuticals Inc.
$41
Global Blood Therapeutics, Inc.
$40
Advanced Accelerator Applications
$37
Agios Pharmaceuticals, Inc.
$36
TESARO, Inc.
$35
Sun Pharmaceutical Industries Inc.
$35
Avyxa Pharma, LLC
$34
Sobi, Inc
$33
TerSera Therapeutics LLC
$33
Janssen Scientific Affairs, LLC
$33
AbbVie Inc.
$32
Puma Biotechnology, Inc.
$32
Pharmacosmos Therapeutics Inc.
$32
Azurity Pharmaceuticals, Inc.
$31
Secura Bio, Inc.
$29
Spectrum Pharmaceuticals Inc.
$29
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Organon LLC
$26
G1 Therapeutics, Inc.
$24
TAIHO ONCOLOGY, INC.
$22
Acrotech Biopharma Inc.
$22
Acrotech Biopharma LLC
$21
Rigel Pharmaceuticals, Inc.
$20
Dova Pharmaceuticals
$20
Jazz Pharmaceuticals Inc.
$20
TG Therapeutics, Inc.
$19
Lexicon Pharmaceuticals, Inc.
$18
GE HealthCare
$18
MorphoSys, US Inc.
$18
Amneal Pharmaceuticals LLC
$18
AMAG Pharmaceuticals, Inc.
$17
Cumberland Pharmaceuticals, Inc.
$17
MACROGENICS, INC.
$17
EUSA Pharma (US) LLC
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$16
CSL Behring
$15
SHIELD THERAPEUTICS INC
$14
SOBI, INC
$13
Sysmex Inostics Inc
$13
Clovis Oncology, Inc.
$12
Servier Pharmaceuticals LLC
$12
Myovant Sciences Inc.
$11
Tactile Systems Technology Inc
$11
Top 3 companies account for 41.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · Abraxane · Actemra · Alecensa · Aliqopa · Aranesp · Avastin · BALVERSA · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CERDELGA · CEREZYME · CHANTIX · COSELA · CREON · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Docivyx · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · FARYDAK · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · PROMACTA · PYRUKYND · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Truqap · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
2
County median income
$64,544
Nearest hospital to ZIP centroid (approximate)
CATAWBA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hanna is a mixed practice specialist, with above-average Medicare volume (top 4% in NC), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hanna experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Hanna performed 9,800 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hanna receive payments from pharmaceutical companies?
Yes. Dr. Hanna received a total of $46,808 from 107 companies across 1,278 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hanna's costs compare to other medical oncologists in Hickory?
Dr. Hanna's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hanna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Hickory
Browse medical oncologists in Hickory ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in NC
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in NC
Which NC medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology